Filing Details
- Accession Number:
- 0001209191-20-048662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-28 17:21:30
- Reporting Period:
- 2020-08-26
- Accepted Time:
- 2020-08-28 17:21:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080709 | Arena Pharmaceuticals Inc | ARNA | Pharmaceutical Preparations (2834) | 232908305 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1302605 | Susan Tina Nova | 6154 Nancy Ridge Drive San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-26 | 1,200 | $14.90 | 17,776 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-26 | 3,600 | $12.70 | 21,376 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-26 | 12,500 | $20.00 | 33,876 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-26 | 17,300 | $67.94 | 16,576 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-26 | 1,200 | $0.00 | 1,200 | $14.90 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-26 | 3,600 | $0.00 | 3,600 | $12.70 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-26 | 12,500 | $0.00 | 12,500 | $20.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-15 | No | 4 | M | Direct | |
| 0 | 2021-06-13 | No | 4 | M | Direct | |
| 0 | 2023-06-13 | No | 4 | M | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.90 to $68.03, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.
- The options vested in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on April 15, 2011, and were exercisable once vested.
- The options vested in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2011, and were exercisable once vested.
- The options vested in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2016, and were exercisable once vested.
Billionaire Hedge Funds
